---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-197129"
form_type: "8-K"
ticker: "CERS"
cik: "0001020214"
company_name: "CERUS CORP"
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T00:29:59.285649+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cerus Q1 revenue up 23% to $59.9M, raises FY product revenue guidance

## Summary
- Product revenue $53.7M (+24% YoY); total revenue $59.9M (+23% YoY).
- Net loss improved to $1.6M ($0.01/sh) from $7.7M ($0.04/sh) a year ago; Non-GAAP adjusted EBITDA $4.0M vs $0.2M.
- Raises full-year 2026 product revenue guidance to $227M-$231M (was $224M-$228M); IFC revenue guided $22M-$24M.
- Signed 4-year supply agreement with Établissement Français du Sang (EFS) for INTERCEPT Blood System and INT200.
- CEO transition: COO Vivek Jayaraman to become CEO effective July 1, 2026; current CEO William Greenman to become executive chairman.

## SEC filing metadata
- accession: 0001193125-26-197129
- form_type: 8-K
- ticker: CERS
- cik: 0001020214
- company_name: CERUS CORP
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1020214/000119312526197129/0001193125-26-197129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1020214/000119312526197129/cers-20260430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-197129
- JSON: https://secwatch.observer/filing/0001193125-26-197129.json
- Plain text: https://secwatch.observer/filing/0001193125-26-197129.txt

## Key facts
- Earnings Releases
  CERUS CORP reported first quarter ended March 31, 2026 results: revenue $59.9 million, net income $1.6 million, or $0.01 per basic and diluted share. Guidance raised.
  - Period: first quarter ended March 31, 2026
  - Revenue: $59.9 million
  - Net income: $1.6 million, or $0.01 per basic and diluted share
  - Guidance: raised
  - Result: reported results
  source text: reference in such filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Cerus Corporation Announces First Quarter 2026 Financial Results First Quarter 2026 Total Revenue of $59.9 million, Up 23% Over Prior Year; First Quarter 2026 Product Revenue of $53.7 million, Up 24% Over Prior Year Raising Full Year Product Revenue Guidance Range to $227 million - $231
  evidence_url: https://www.sec.gov/Archives/edgar/data/1020214/000119312526197129/0001193125-26-197129-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.